mansteron p

Geno Masteron P (Drostanolone Propionate) | NexorinPharma

Geno Masteron P is an injectable anabolic steroid containing Drostanolone Propionate per milliliter. At NexorinPharma, we carry Geno Masteron P as part of our injectable anabolic steroid inventory for customers in markets where Drostanolone Propionate is legally available.

Drostanolone Propionate is the active compound in Geno Masteron P. It is the short-acting propionate ester form of Drostanolone, an anabolic steroid widely referenced in bodybuilding and performance communities under the brand name Masteron. The propionate ester produces a half-life of approximately 2 to 3 days, making it a faster-acting preparation requiring more frequent administration compared to the longer-acting Drostanolone Enanthate form.

Like all anabolic-androgenic steroids, Geno Masteron P carries significant health and legal considerations. This page covers what Drostanolone Propionate is, how it works, and what health and legal considerations apply. It does not constitute medical advice. It does not recommend or encourage steroid use. It does not provide dosage, cycle, or stacking guidance of any kind.

Product Specifications

Website: nexorinpharma.com Product Name: Geno Masteron P Manufacturer: Geno Active Compound: Drostanolone Propionate Also Known As: Masteron Propionate, Mast P, Drostanolone P Drug Class: Anabolic-androgenic steroid, DHT derivative, injectable Ester: Propionate Half-Life: Approximately 2 to 3 days Presentation: Injectable solution Form: Oil-based injectable Route of Administration: Intramuscular injection Anabolic Rating: 62 to 130 relative to testosterone baseline of 100 Androgenic Rating: 25 to 40 relative to testosterone baseline of 100 Aromatization: None Anti-Estrogenic Activity: Mild aromatase inhibition 17-Alpha Alkylated: No Liver Toxicity: Low Legal Status: Schedule III controlled substance in the United States. Prescription required. Legal status varies by country.

About Geno

Geno is a non-prescription anabolic steroid manufacturer producing injectable and oral anabolic steroid products for markets where such compounds are legally available. The brand carries a presence in international bodybuilding and performance communities and produces its product range with pharmaceutical-style presentation and clear compound labeling.

Like all manufacturers operating outside regulated pharmaceutical channels, Geno does not carry the manufacturing oversight, regulatory scrutiny, or clinical trial documentation of pharmaceutical grade prescription products. Consequently, quality, purity, and concentration accuracy are less verifiable than with regulated products. Within the non-prescription market, however, Geno is referenced for product presentation and labeling clarity across international performance communities.

What Is Drostanolone Propionate

Drostanolone is a synthetic anabolic-androgenic steroid derived from Dihydrotestosterone. Syntex developed it in the 1950s and introduced it to the market under the brand name Masteron. From the beginning, it was developed with a specific clinical application in mind: the treatment of inoperable breast cancer in women. This clinical origin distinguishes Drostanolone from many other anabolic steroids developed primarily for performance or general anabolic applications.

Structurally, Drostanolone is a DHT derivative with a methyl group at the second carbon position of the steroid structure. This modification prevents the compound from being metabolized by the 3-hydroxysteroid dehydrogenase enzyme in muscle tissue, preserving its anabolic activity. As a DHT derivative, Drostanolone does not convert to estrogen through the aromatase enzyme pathway. In addition, it carries mild aromatase inhibiting properties, partially reducing estrogen conversion from other aromatizing compounds.

The propionate ester attached to the base Drostanolone compound determines its release rate and duration of activity. Propionate is a short-acting ester producing a half-life of approximately 2 to 3 days. As a result, Geno Masteron P provides faster onset of Drostanolone activity compared to the longer-acting Drostanolone Enanthate format, though it requires more frequent administration to maintain stable plasma concentrations.

How Drostanolone Propionate Works

After intramuscular injection, the oil-based preparation deposits at the injection site. Enzymes in the body gradually separate the propionate ester from the Drostanolone molecule. Free Drostanolone then enters the bloodstream and becomes active throughout the body.

Androgen Receptor Binding

Drostanolone binds to androgen receptors throughout the body. Its androgenic activity is moderate compared to testosterone. As a result, androgen receptor activation in muscle tissue drives its anabolic effects while producing comparatively lower androgenic activity in androgen-sensitive tissues compared to testosterone-based compounds.

Nitrogen Retention

Drostanolone Propionate produces positive nitrogen retention in muscle tissue. The body retains more nitrogen than it excretes. Consequently, this supports an anabolic environment that favors muscle repair and preservation. This mechanism contributes to the lean muscle maintenance observations consistently discussed in performance communities about Drostanolone use.

Protein Synthesis

Drostanolone Propionate accelerates protein synthesis in skeletal muscle tissue. Faster protein synthesis supports muscle repair and maintenance following training. This mechanism is directly tied to its androgen receptor activity and contributes to its anabolic profile in both clinical and performance contexts.

No Aromatization

Drostanolone Propionate does not convert to estrogen through the aromatase enzyme pathway. As a DHT derivative, it is not a substrate for aromatase. Consequently, estrogen-related side effects including water retention and gynecomastia are not part of its direct pharmacological profile. This characteristic is one of the most consistently referenced pharmacological distinctions of Drostanolone in performance community discussions.

Mild Aromatase Inhibition

Drostanolone carries mild aromatase inhibiting properties. By partially inhibiting the aromatase enzyme, it reduces the rate of estrogen conversion from other aromatizing compounds present in the body. This mild anti-estrogenic activity is moderate compared to dedicated aromatase inhibitors such as Anastrozole or Exemestane. However, it is a pharmacologically relevant characteristic that distinguishes Drostanolone from most other injectable anabolic steroids.

No Progestogenic Activity

Drostanolone Propionate does not show clinically significant affinity for progesterone receptors. This distinguishes it from compounds like Trenbolone and Nandrolone where progestogenic activity is a primary side effect consideration. As a result, Geno Masteron P carries a cleaner overall side effect profile compared to progestogenic anabolic steroids.

Why the Propionate Ester Distinguishes Geno Masteron P

The propionate ester produces a half-life of approximately 2 to 3 days. This short half-life produces faster onset of Drostanolone activity following injection compared to the longer-acting enanthate ester. However, it also requires more frequent administration to maintain stable plasma concentrations.

Compare that to Drostanolone Enanthate. The enanthate ester produces a half-life of approximately 10 to 12 days, requiring significantly less frequent injection. The propionate ester in Geno Masteron P produces faster onset and faster clearance. This faster clearance is consistently referenced in performance community discussions as a practical distinction between Masteron Propionate and Masteron Enanthate.

Clinical Background

Drostanolone carries a documented clinical history that provides relevant context for its pharmacological profile and distinguishes it from many anabolic steroids discussed in performance communities.

Breast Cancer Treatment

Drostanolone was developed and used clinically for the treatment of inoperable breast cancer in women. Its anti-estrogenic properties through mild aromatase inhibition and androgen receptor activity made it a relevant clinical compound for hormone-sensitive breast cancer management. This clinical application gave Drostanolone a documented medical history that most anabolic steroids discussed in performance communities do not carry.

Clinical Withdrawal

Drostanolone’s clinical use for breast cancer treatment has largely been replaced by more modern targeted hormone therapies including selective estrogen receptor modulators and dedicated aromatase inhibitors. As a result, it is no longer widely used in clinical oncology settings in most markets. Its continued presence in performance communities developed independently of its clinical application history.

Geno Masteron P Versus Other Injectable Anabolic Steroids

Versus Drostanolone Enanthate

Both Drostanolone Propionate and Drostanolone Enanthate contain Drostanolone as the active compound and carry identical pharmacological profiles. The distinction is the ester and injection frequency. Geno Masteron P uses the short-acting propionate ester with a half-life of 2 to 3 days, requiring more frequent injection. Drostanolone Enanthate uses the longer-acting enanthate ester with a half-life of approximately 10 to 12 days, requiring less frequent administration. Both produce identical Drostanolone-mediated pharmacological effects once the active compound is released from the respective esters.

Versus Methenolone Enanthate (Primobolan Depot)

Both Drostanolone Propionate and Methenolone Enanthate are non-aromatizing DHT derivative injectable anabolic steroids. Both carry mild side effect profiles compared to most injectable anabolic steroids. However, Drostanolone carries mild aromatase inhibiting properties that Methenolone does not. In addition, Drostanolone’s androgenic activity is more pronounced than Methenolone’s moderate androgenic profile. As a result, both compounds are referenced in performance communities for non-aromatizing profiles but with distinct pharmacological differences.

Versus Testosterone Propionate

Both preparations use the propionate ester producing comparable half-lives of approximately 2 to 3 days. However, testosterone aromatizes to estrogen while Drostanolone Propionate does not. Testosterone carries an anabolic rating of 100 and androgenic rating of 100 while Drostanolone carries significantly lower ratings. As a result, Geno Masteron P produces a milder anabolic profile with a significantly cleaner estrogenic side effect picture compared to Testosterone Propionate.

Versus Trenbolone Acetate

Trenbolone Acetate uses a comparable short-acting acetate ester but carries anabolic and androgenic ratings of 500 each compared to Drostanolone’s significantly lower ratings. Trenbolone also shows progestogenic activity and produces a significantly more aggressive side effect profile than Drostanolone. Geno Masteron P consequently represents a considerably milder pharmacological profile than Trenbolone Acetate across virtually all parameters.

Versus Stanozolol Injectable

Injectable Stanozolol is another non-aromatizing anabolic steroid discussed in performance communities. Unlike Geno Masteron P, injectable Stanozolol carries water-based formulation considerations and a distinct hepatotoxicity profile from its 17-alpha alkylated structure even in injectable form. Drostanolone Propionate’s oil-based non-alkylated injectable format produces a lower liver stress profile than injectable Stanozolol. As a result, Geno Masteron P represents a more favorable hepatotoxicity profile than injectable Stanozolol.

Side Effects and Health Risks

Geno Masteron P carries one of the milder side effect profiles among injectable anabolic steroids. These risks remain real and should not be minimized.

Androgenic Effects

Despite its relatively moderate androgenic rating, Drostanolone Propionate still produces androgenic side effects in susceptible individuals. These include accelerated hair loss in genetically predisposed individuals and acne on the face and back. In women, virilization effects including voice deepening and changes in body hair distribution are serious considerations even with milder androgenic compounds.

Cardiovascular Effects

Drostanolone Propionate produces adverse lipid profile changes. HDL cholesterol decreases while LDL cholesterol increases. These lipid changes carry long-term cardiovascular health implications. Regular lipid monitoring is therefore important for anyone using this compound despite its milder overall side effect profile compared to more potent anabolic steroids.

Hormonal Suppression

Drostanolone Propionate suppresses the hypothalamic-pituitary-gonadal axis and the body’s natural testosterone production. The degree of suppression is generally considered less pronounced than with more potent anabolic steroids. However, post-use hormonal disruption remains a relevant consideration. In some cases, it results in hypogonadism requiring medical treatment.

Injection Site Reactions

As an oil-based intramuscular injectable with a short-acting propionate ester, Geno Masteron P requires more frequent injection than longer-acting preparations. More frequent injection consequently increases cumulative injection site reaction risk including pain, swelling, and in rare cases infection. Proper injection technique, sterile practices, and injection site rotation are therefore essential for anyone using this preparation.

Psychological Effects

Anabolic steroid use carries documented associations with mood changes and irritability. These considerations apply to Drostanolone Propionate use. They are generally less pronounced than with higher androgenic compounds but remain relevant health considerations.

Legal and Regulatory Status

Drostanolone Propionate carries Schedule III controlled substance status in the United States under the Controlled Substances Act. Possession without a valid prescription is a federal offense.

In the United Kingdom, Drostanolone Propionate falls under Class C of the Misuse of Drugs Act. Supply is illegal.

The World Anti-Doping Agency bans Drostanolone Propionate alongside all major athletic governing bodies. It consequently appears on prohibited substance lists across Olympic sports, professional athletics, and competitive bodybuilding organizations that conduct testing.

You are responsible for confirming the legal status of Drostanolone Propionate in your specific jurisdiction before purchasing from NexorinPharma.

Frequently Asked Questions

Is Geno Masteron P Available at NexorinPharma

Yes. NexorinPharma carries Geno Masteron P for customers in markets where Drostanolone Propionate is legally available. Visit nexorinpharma.com to check current availability and pricing.

What Is the Half-Life of Geno Masteron P

The propionate ester produces a half-life of approximately 2 to 3 days. As a result, more frequent injection is required to maintain stable Drostanolone plasma concentrations compared to longer-acting Drostanolone Enanthate preparations.

Does Drostanolone Propionate Aromatize

No. Drostanolone Propionate does not convert to estrogen through the aromatase enzyme pathway. As a DHT derivative, it is not a substrate for aromatase. Furthermore, it carries mild aromatase inhibiting properties that partially reduce estrogen conversion from other aromatizing compounds.

How Does Geno Masteron P Compare to Drostanolone Enanthate

Both preparations contain Drostanolone as the active compound and carry identical pharmacological profiles. The distinction is the ester and injection frequency. Geno Masteron P uses the propionate ester with a half-life of 2 to 3 days requiring more frequent injection. Drostanolone Enanthate uses the enanthate ester with a half-life of approximately 10 to 12 days requiring less frequent administration.

What Are the Most Serious Health Risks

Cardiovascular effects from lipid dysregulation and hormonal suppression are the most clinically significant concerns with Drostanolone Propionate. Androgenic effects, injection site reactions from more frequent propionate ester administration, and psychological impacts complete the primary risk profile. Medical supervision and regular blood work monitoring are therefore essential for anyone using this compound.

Is Geno Masteron P Legal to Purchase

Drostanolone Propionate carries Schedule III controlled substance status in the United States and requires a valid prescription. Legal status varies by jurisdiction. You are responsible for confirming the legal status in your jurisdiction before purchasing from NexorinPharma.

What to Consider Before Purchasing Geno Masteron P

Drostanolone Propionate has a documented clinical history in breast cancer treatment and a well-established presence in bodybuilding and performance community discussions. Its non-aromatizing profile, mild anti-estrogenic properties, and relatively favorable side effect profile compared to most injectable anabolic steroids contribute to its consistent discussion in performance communities.

The Geno non-prescription format does not carry the manufacturing oversight of pharmaceutical grade products. The clinical and observational research base for Drostanolone applies to its pharmacological profile and risk profile regardless of the specific manufacturer or format. Furthermore, the more frequent injection requirement of the propionate ester introduces additional injection site and sterile practice considerations compared to longer-acting preparations.

Drostanolone Propionate carries documented cardiovascular, hormonal, androgenic, and psychological health risks. These risks require medical supervision to manage responsibly. Consulting a licensed medical professional is the appropriate starting point for anyone with health concerns related to anabolic steroid use.

For customers in markets where Drostanolone Propionate is legally available, visit nexorinpharma.com to check current Geno Masteron P availability, pricing, and stock levels.